Journal Watch - First in human Trial
-
First-in-human Trial of Sorbent-assisted Continuous Flow PD
One downside of peritoneal dialysis (PD) is the need to truck bags of sterile fluid to patients. A new sorbent-assisted PD (SAPD) device regenerates spent dialysate. SAPD may improve uremic solute clearance by maintaining a high concentration gradient and increasing the mass transfer area coefficient. It may help preserve peritoneal membranes longer by avoiding high glucose concentrations. And, fewer connections may mean less peritonitis. Short-term safety and performance of SAPD will be evaluated in a group of 12 stable adulte PD patients.
Read the abstract » | (added 2025-10-14)
Tags: First in human Trial, Continuous Flow Peritoneal Dialysis, Sorbent assisted Peritoneal Dialysis, Sapd, Peritonitis

